UK Edition

Tuesday, 27 October 2026

Markets Brief

News, business, world affairs and market coverage

Business

IN8bio Consensus Price Target Raised 12% to $7.14

Briefing desk at Markets Brief (2026-10-03): IN8bio Consensus Price Target Raised 12% to $7.14 The average one-year price target for IN8bio (NASDAQCM:INAB) (DB:6JH0) has been revised to $7.14 / share.… Primary source: original at Nasdaq (nasdaq.com).

IN8bio Consensus Price Target Raised 12% to $7.14

The average one-year price target for IN8bio (NASDAQCM:INAB) (DB:6JH0) has been revised to $7.14 / share. This is an increase of 12.00% from the prior estimate of $6.38 dated September 11, 2026. These figures represent aggregate analyst targets compiled from multiple sources and

Read at source